Zai Lab Limited (NASDAQ:ZLAB) went up by 12.01% from its latest closing price compared to the recent 1-year high of $178.91. The company’s stock price has collected 35.58% of gains in the last five trading sessions.
Is It Worth Investing in Zai Lab Limited (NASDAQ :ZLAB) Right Now?
Plus, the 36-month beta value for ZLAB is at 1.27. Opinions of the stock are interesting as 15 analysts out of 15 who provided ratings for Zai Lab Limited declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $96.61, which is $75.4 above the current price. ZLAB currently public float of 94.10M and currently shorts hold a 3.42% ratio of that float. Today, the average trading volume of ZLAB was 643.59K shares.
ZLAB’s Market Performance
ZLAB stocks went up by 35.58% for the week, with a monthly drop of -11.55% and a quarterly performance of -23.70%, while its annual performance rate touched -79.72%. The volatility ratio for the week stands at 12.85% while the volatility levels for the past 30 days are set at 10.88% for Zai Lab Limited. The simple moving average for the period of the last 20 days is 13.76% for ZLAB stocks with a simple moving average of -49.06% for the last 200 days.
Analysts’ Opinion of ZLAB
Many brokerage firms have already submitted their reports for ZLAB stocks, with Macquarie repeating the rating for ZLAB by listing it as a “Outperform.” The predicted price for ZLAB in the upcoming period, according to Macquarie is $64 based on the research report published on January 21st of the current year 2022.
ZLAB Trading at -4.93% from the 50-Day Moving Average
After a stumble in the market that brought ZLAB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -81.81% of loss for the given period.
Volatility was left at 10.88%, however, over the last 30 days, the volatility rate increased by 12.85%, as shares sank -12.22% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -25.21% lower at present.
During the last 5 trading sessions, ZLAB rose by +35.58%, which changed the moving average for the period of 200-days by -77.65% in comparison to the 20-day moving average, which settled at $28.38. In addition, Zai Lab Limited saw -48.23% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at ZLAB starting from DIEKMAN JOHN D, who sale 1,000 shares at the price of $50.17 back on Feb 04. After this action, DIEKMAN JOHN D now owns 67,615 shares of Zai Lab Limited, valued at $50,170 using the latest closing price.
Lis William, the Director of Zai Lab Limited, sale 1,926 shares at $53.40 during a trade that took place back on Jan 20, which means that Lis William is holding 34,114 shares at $102,848 based on the most recent closing price.
Stock Fundamentals for ZLAB
Current profitability levels for the company are sitting at:
- -485.10 for the present operating margin
- +63.80 for the gross margin
The net margin for Zai Lab Limited stands at -488.16. The total capital return value is set at -54.17, while invested capital returns managed to touch -54.75. Equity return is now at value -37.30, with -32.90 for asset returns.
Based on Zai Lab Limited (ZLAB), the company’s capital structure generated 1.13 points at debt to equity in total, while total debt to capital is 1.11. Total debt to assets is 0.97, with long-term debt to equity ratio resting at 0.70. Finally, the long-term debt to capital ratio is 0.69.
When we switch over and look at the enterprise to sales, we see a ratio of 5.87, with the company’s debt to enterprise value settled at 0.00. The receivables turnover for the company is 4.80 and the total asset turnover is 0.10. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.78.